Aethlon Medical

Aethlon Medical

Medical Devices, 9635 Granite RDG Dr Ste 100, San Diego, California, 92123, United States, 11-50 Employees

aethlonmedical.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 85********

Who is AETHLON MEDICAL

Aethlon Medical is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening ...

Read More

map
  • 9635 Granite RDG Dr Ste 100, San Diego, California, 92123, United States Headquarters: 9635 Granite RDG Dr Ste 100, San Diego, California, 92123, United States
  • 1999 Date Founded: 1999
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies
  • Steve Robinson CEO:   Steve Robinson

industries-icon Industry: Medical Devices

SIC SIC Code: 3841 | NAICS Code: 339113 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AETHLON MEDICAL

Aethlon Medical Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Aethlon Medical

Answer: Aethlon Medical's headquarters are located at 9635 Granite RDG Dr Ste 100, San Diego, California, 92123, United States

Answer: Aethlon Medical's phone number is 85********

Answer: Aethlon Medical's official website is https://aethlonmedical.com

Answer: Aethlon Medical's revenue is $10 Million to $25 Million

Answer: Aethlon Medical's SIC: 3841

Answer: Aethlon Medical's NAICS: 339113

Answer: Aethlon Medical has 11-50 employees

Answer: Aethlon Medical is in Medical Devices

Answer: Aethlon Medical contact info: Phone number: 85******** Website: https://aethlonmedical.com

Answer: Aethlon Medical is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses and harmful exosomes from blood utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access